melatonin has been researched along with Atheroma in 7 studies
Excerpt | Relevance | Reference |
---|---|---|
"Melatonin (MLT) is an endogenous indole compound with numerous biological activities that has been associated with atherosclerosis (AS)." | 7.81 | Melatonin alleviates myosin light chain kinase expression and activity via the mitogen-activated protein kinase pathway during atherosclerosis in rabbits. ( Cheng, X; Wan, Y; Wang, Y; Xu, Y; Zhou, Q; Zhu, H, 2015) |
"Melatonin (MLT) is an endogenous indole compound with numerous biological activities that has been associated with atherosclerosis (AS)." | 3.81 | Melatonin alleviates myosin light chain kinase expression and activity via the mitogen-activated protein kinase pathway during atherosclerosis in rabbits. ( Cheng, X; Wan, Y; Wang, Y; Xu, Y; Zhou, Q; Zhu, H, 2015) |
"Melatonin has atheroprotective effects by acting on different pathogenic signaling processes; these result from its direct free radical scavenger activity, its indirect antioxidant properties and its anti-inflammatory actions." | 2.50 | Melatonin and its atheroprotective effects: a review. ( Favero, G; Reiter, RJ; Rezzani, R; Rodella, LF, 2014) |
"High-dose melatonin enhanced atherosclerotic plaque stability in ApoE mice in vivo by inducing the expression of P4Hα1, which was reversed by MTM." | 1.51 | Melatonin enhances atherosclerotic plaque stability by inducing prolyl-4-hydroxylase α1 expression. ( Chen, W; Jiang, X; Li, H; Li, J; Liu, S; Liu, Y; Yang, J; Zhang, C; Zhang, W, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Maity, J | 3 |
Dey, T | 3 |
Banerjee, A | 3 |
Chattopadhyay, A | 3 |
Das, AR | 3 |
Bandyopadhyay, D | 3 |
Hu, ZP | 1 |
Fang, XL | 1 |
Sheng, B | 1 |
Guo, Y | 1 |
Yu, YQ | 1 |
Ma, S | 1 |
Chen, J | 1 |
Feng, J | 1 |
Zhang, R | 1 |
Fan, M | 1 |
Han, D | 1 |
Li, X | 1 |
Li, C | 1 |
Ren, J | 1 |
Wang, Y | 2 |
Cao, F | 1 |
Li, H | 1 |
Li, J | 1 |
Jiang, X | 1 |
Liu, S | 1 |
Liu, Y | 1 |
Chen, W | 1 |
Yang, J | 1 |
Zhang, C | 1 |
Zhang, W | 1 |
Ding, S | 1 |
Lin, N | 1 |
Sheng, X | 1 |
Zhao, Y | 1 |
Su, Y | 1 |
Xu, L | 1 |
Tong, R | 1 |
Yan, Y | 1 |
Fu, Y | 1 |
He, J | 1 |
Gao, Y | 1 |
Yuan, A | 1 |
Ye, L | 1 |
Reiter, RJ | 2 |
Pu, J | 1 |
Favero, G | 1 |
Rodella, LF | 1 |
Rezzani, R | 1 |
Cheng, X | 1 |
Wan, Y | 1 |
Xu, Y | 1 |
Zhou, Q | 1 |
Zhu, H | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Intervention Effect Of Melatonin On The Risk Of Cardiovascular Events And Malignant Tumors In The Elderly: A Prospective, Randomized Parallel Controlled Study Based On Large Cohorts[NCT04631341] | 10,000 participants (Anticipated) | Interventional | 2021-01-01 | Not yet recruiting | |||
Melatonin and Essential Arterial Hypertension[NCT05257291] | Phase 2 | 23 participants (Actual) | Interventional | 2018-02-02 | Active, not recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for melatonin and Atheroma
Article | Year |
---|---|
Melatonin ameliorates myocardial infarction in obese diabetic individuals: The possible involvement of macrophage apoptotic factors.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cholesterol; Diabetes Mellitus, Type 2; Humans; M | 2023 |
Melatonin ameliorates myocardial infarction in obese diabetic individuals: The possible involvement of macrophage apoptotic factors.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cholesterol; Diabetes Mellitus, Type 2; Humans; M | 2023 |
Melatonin ameliorates myocardial infarction in obese diabetic individuals: The possible involvement of macrophage apoptotic factors.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cholesterol; Diabetes Mellitus, Type 2; Humans; M | 2023 |
Melatonin ameliorates myocardial infarction in obese diabetic individuals: The possible involvement of macrophage apoptotic factors.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cholesterol; Diabetes Mellitus, Type 2; Humans; M | 2023 |
Melatonin and its atheroprotective effects: a review.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Atherosclerosis; Gene Expression Regulation; Humans | 2014 |
5 other studies available for melatonin and Atheroma
Article | Year |
---|---|
Melatonin inhibits macrophage infiltration and promotes plaque stabilization by upregulating anti-inflammatory HGF/c-Met system in the atherosclerotic rabbit: USPIO-enhanced MRI assessment.
Topics: Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aortic Diseases; Atherosclerosis; Contrast Medi | 2020 |
Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition.
Topics: Animals; Atherosclerosis; Disease Progression; Forkhead Box Protein O3; Free Radical Scavengers; Inf | 2018 |
Melatonin enhances atherosclerotic plaque stability by inducing prolyl-4-hydroxylase α1 expression.
Topics: Animals; Apolipoproteins E; Cell Line; Central Nervous System Depressants; Chromones; Enzyme Inhibit | 2019 |
Melatonin stabilizes rupture-prone vulnerable plaques via regulating macrophage polarization in a nuclear circadian receptor RORα-dependent manner.
Topics: Animals; Atherosclerosis; Humans; Macrophages; Male; Melatonin; Mice; Mice, Knockout, ApoE; Nuclear | 2019 |
Melatonin alleviates myosin light chain kinase expression and activity via the mitogen-activated protein kinase pathway during atherosclerosis in rabbits.
Topics: Animals; Aorta; Atherosclerosis; Capillary Permeability; Disease Models, Animal; Extracellular Signa | 2015 |